Wall Street Experts
ver. ZuMIgo(08/25)
Anika Therapeutics, Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 164
EBIT TTM (mln): -34
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
22 |
23 |
24 |
25 |
Rok finansowy |
1999 |
2000 |
2001 |
2002 |
2003 |
2004 |
2005 |
2006 |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
14 |
16 |
11 |
13 |
15 |
26 |
30 |
27 |
31 |
36 |
40 |
56 |
65 |
71 |
75 |
106 |
93 |
103 |
113 |
106 |
115 |
130 |
148 |
156 |
167 |
120 |
Przychód Δ r/r |
0.0% |
21.0% |
-30.8% |
16.6% |
16.8% |
71.8% |
12.7% |
-10.0% |
14.9% |
16.1% |
12.2% |
38.4% |
16.6% |
10.2% |
5.2% |
40.6% |
-11.9% |
11.2% |
9.7% |
-6.9% |
8.6% |
13.8% |
13.3% |
5.7% |
6.7% |
-28.1% |
Marża brutto |
60.7% |
46.9% |
27.3% |
38.5% |
48.0% |
62.4% |
62.6% |
58.6% |
61.5% |
63.1% |
65.9% |
57.1% |
58.7% |
59.4% |
69.7% |
80.2% |
77.4% |
76.8% |
75.9% |
70.4% |
74.9% |
52.9% |
56.1% |
59.9% |
61.9% |
63.4% |
EBIT (mln) |
-0 |
-1 |
-7 |
-3 |
1 |
6 |
9 |
5 |
7 |
4 |
6 |
8 |
14 |
20 |
33 |
61 |
48 |
51 |
46 |
22 |
34 |
-14 |
-18 |
-19 |
-25 |
-5 |
EBIT Δ r/r |
0.0% |
883.4% |
653.6% |
-55.8% |
-118.2% |
973.6% |
33.9% |
-36.5% |
21.4% |
-35.8% |
32.2% |
34.9% |
85.3% |
41.2% |
65.4% |
88.4% |
-21.7% |
5.1% |
-9.6% |
-52.4% |
57.5% |
-142.2% |
27.7% |
5.0% |
31.2% |
-80.0% |
EBIT (%) |
-0.7% |
-6.0% |
-65.5% |
-24.8% |
3.9% |
24.1% |
28.7% |
20.2% |
21.4% |
11.8% |
13.9% |
13.6% |
21.6% |
27.6% |
43.4% |
58.2% |
51.8% |
49.0% |
40.3% |
20.6% |
29.9% |
-11.1% |
-12.5% |
-12.4% |
-15.3% |
-4.3% |
Koszty finansowe (mln) |
-0 |
-1 |
-1 |
-0 |
-0 |
-0 |
-1 |
-2 |
-2 |
-0 |
4 |
0 |
0 |
5 |
-0 |
-0 |
-0 |
-0 |
-0 |
-1 |
0 |
-0 |
-0 |
1 |
2 |
0 |
EBITDA (mln) |
1 |
0 |
-6 |
-2 |
2 |
7 |
9 |
6 |
7 |
6 |
11 |
11 |
18 |
25 |
32 |
61 |
48 |
51 |
46 |
22 |
34 |
-1 |
-40 |
-19 |
-11 |
-5 |
EBITDA(%) |
5.9% |
1.3% |
-54.6% |
-16.5% |
10.4% |
26.8% |
30.2% |
21.7% |
24.0% |
15.8% |
27.9% |
19.5% |
27.7% |
34.7% |
42.7% |
58.2% |
51.8% |
49.0% |
40.3% |
20.6% |
29.9% |
-0.5% |
-26.8% |
-12.4% |
-6.7% |
-4.3% |
Podatek (mln) |
2 |
0 |
0 |
0 |
-0 |
-4 |
4 |
3 |
3 |
1 |
2 |
3 |
5 |
8 |
12 |
23 |
17 |
18 |
14 |
4 |
9 |
-5 |
-2 |
-4 |
-3 |
6 |
Zysk Netto (mln) |
-2 |
0 |
-7 |
-3 |
1 |
11 |
6 |
5 |
6 |
4 |
4 |
4 |
8 |
12 |
21 |
38 |
31 |
33 |
32 |
19 |
27 |
-24 |
4 |
-15 |
-83 |
-56 |
Zysk netto Δ r/r |
0.0% |
-106.9% |
-3993.7% |
-55.0% |
-127.2% |
1253.1% |
-47.3% |
-21.9% |
31.1% |
-39.9% |
1.6% |
17.0% |
96.2% |
38.9% |
75.0% |
86.2% |
-19.7% |
5.8% |
-2.2% |
-41.2% |
45.2% |
-188.2% |
-117.2% |
-459.4% |
456.3% |
-31.8% |
Zysk netto (%) |
-18.5% |
1.1% |
-59.7% |
-23.1% |
5.4% |
42.3% |
19.8% |
17.2% |
19.6% |
10.1% |
9.2% |
7.8% |
13.1% |
16.5% |
27.4% |
36.3% |
33.1% |
31.5% |
28.1% |
17.7% |
23.7% |
-18.4% |
2.8% |
-9.5% |
-49.6% |
-47.0% |
EPS |
-0.26 |
0.0175 |
-0.68 |
-0.31 |
0.08 |
0.98 |
0.57 |
0.43 |
0.55 |
0.32 |
0.32 |
0.34 |
0.65 |
0.89 |
1.46 |
2.61 |
2.06 |
2.22 |
2.18 |
1.3 |
1.93 |
-1.69 |
0.29 |
-1.02 |
-5.64 |
-3.83 |
EPS (rozwodnione) |
-0.24 |
0.0175 |
-0.68 |
-0.31 |
0.08 |
0.98 |
0.52 |
0.41 |
0.53 |
0.32 |
0.32 |
0.32 |
0.62 |
0.82 |
1.39 |
2.51 |
2.01 |
2.15 |
2.11 |
1.27 |
1.89 |
-1.69 |
0.28 |
-1.02 |
-5.64 |
-3.83 |
Ilośc akcji (mln) |
10 |
10 |
10 |
10 |
10 |
11 |
10 |
11 |
11 |
11 |
11 |
13 |
13 |
13 |
14 |
15 |
15 |
15 |
15 |
14 |
14 |
14 |
14 |
15 |
15 |
15 |
Ważona ilośc akcji (mln) |
10 |
10 |
10 |
10 |
11 |
11 |
11 |
11 |
11 |
11 |
12 |
14 |
14 |
14 |
15 |
15 |
15 |
15 |
15 |
15 |
14 |
14 |
15 |
15 |
15 |
15 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |